Screening for Fetal Chromosomal Abnormalities
Publication Date: October 1, 2020
Last Updated: March 14, 2022
Recommendations
Prenatal genetic screening (serum screening with or without nuchal translucency [NT] ultrasound or cell-free DNA screening) and diagnostic testing (chorionic villus sampling [CVS] or amniocentesis) options should be discussed and offered to all pregnant women regardless of maternal age or risk of chromosomal abnormality. After review and discussion, every patient has the right to pursue or decline prenatal genetic screening and diagnostic testing. (A)
328407
Title
Screening for Fetal Chromosomal Abnormalities
Authoring Organization
American College of Obstetricians and Gynecologists